Gould B A, Hornung R S, Kieso H, Mann S, Raftery E B
Br J Clin Pharmacol. 1982 Dec;14(6):827-31. doi: 10.1111/j.1365-2125.1982.tb02044.x.
1 We have assessed the efficacy of Viskaldix, a combination of pindolol 10 mg and clopamide 5 mg using continuous intra-arterial ambulatory blood pressure monitoring. 2 Fourteen of the sixteen patients entered were studied on no therapy and following a minimum of 6 weeks at a constant dosage of Viskaldix. 3 Viskaldix produced a marked and consistent reduction of the blood pressure over the 24 h. The diurnal variation in the heart rate was decreased. 4 The results were compared with those of a similar study with once-daily pindolol where there was control during the day but not in the early morning when the blood pressures rose rapidly.
我们使用连续动脉动态血压监测评估了维斯卡迪克斯(Viskaldix,含10毫克吲哚洛尔和5毫克氯噻酮的复方制剂)的疗效。
入选的16名患者中有14名未接受治疗,而是在至少6周内持续服用恒定剂量的维斯卡迪克斯进行研究。
维斯卡迪克斯在24小时内使血压显著且持续降低。心率的昼夜变化减小。
将这些结果与一项类似的关于每日一次服用吲哚洛尔的研究结果进行了比较,在该研究中,白天血压得到控制,但在清晨血压迅速上升时未得到控制。